Contraceptive choice for young people

Journal of Family Planning and Reproductive Health Care

Volumn 35, Issue 2, 2009, Pages 81-85

  Say, Rebecca ^a   Mansour, Diana ^b,c  

^a NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b Newcastle Contraceptive and Sexual Health Service   (United Kingdom)

^c NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

Author keywords

Combined hormonal patch; Combined hormonal vaginal ring; Long acting reversible contraceptives; Single rod implant; Young people

Indexed keywords

ACCESS TO INFORMATION; ADOLESCENT; ADULT; AGE; ARTICLE; ATTITUDE TO HEALTH; ATTITUDE TO PREGNANCY; CLINICAL EFFECTIVENESS; CONTRACEPTION; FEMALE; FEMALE CONTRACEPTIVE DEVICE; HEALTH CARE QUALITY; HUMAN; INVASIVE PROCEDURE; KNOWLEDGE; PERCEPTION; PERSONAL EXPERIENCE; QUALITATIVE ANALYSIS; RISK BENEFIT ANALYSIS; SAFETY; SIDE EFFECT; SINGLE ROD IMPLANT; TRANSDERMAL PATCH; UNPLANNED PREGNANCY; VAGINA RING;

CHOICE BEHAVIOR; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVE DEVICES, FEMALE; CROSS-SECTIONAL STUDIES; DECISION MAKING; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; PREGNANCY; YOUNG ADULT;

EID: 65249178308     PISSN: 14711893     EISSN: None     Source Type: Journal    
DOI: 10.1783/147118909787931780     Document Type: Article

References (9)

1. Vanhegan G. Contraception in the under-16s; issues of confidentiality and choice of methods. The Obstetrician and Gynaecologist 2008; 10: 22-26.
2. Anonymous. Contraception in teenagers. Drug Ther Bull 2002; 40: 92-95.
3. Potter LS. How effective are contraceptives? The determination and measurement of pregnancy rates. Obstet Gynecol 1996; 88: 13S-23S.
4. National Institute for Health and Clinical Excellence. Long-Acting Reversible Contraception (Clinical Guideline CG30). October 2005. http://www.nice.org.uk/Guidance/CG30/Guidance/pdf/English [Accessed 5 July 2008].
5. Dabrow S, Merrick CL, Conlon M. Adolescent girls' attitudes toward contraceptive subdermal implants. J Adolesc Health 1995; 16: 360-366.
6. Edwards JE, Oldman A, Smith L, McQuay HJ, Moore RA. Women's knowledge of, and attitude to, contraceptive effectiveness and adverse health effects. Br J Fam Plann 2000; 26: 73-80.
7. Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit. New Product Review (September 2003). Norelgestromin/ ethinyl oestradiol transdermal contraceptive system (Evra®). J Fam Plann Reprod Health Care 2004; 30: 43-45.
8. N Shimoni, C Westhoff. Review of the vaginal contraceptive ring (NuvaRing®). J Fam Plann Reprod Health Care 2008; 34: 247-250.
9. Novak A, de la Loge C, Abetz L, van der Meulen E. The combined contraceptive vaginal ring, NuvaRing: an international study of user acceptability. Contraception 2003; 67: 187-194.